Prevention program "Hello Baby" established nationwide in Germany

22

Aug 2019

With the preventive program for pregnant women, "Hello Baby," premature births and infection-related birth complications should be minimized. Now the program has been established nationwide: 60 health insurance companies offer to their approximately 6.5 million insured since July 1, 2019, the additional tests contained therein.

The program was developed in cooperation of health insurance funds together with the Professional Association of Gynecologists, the Professional Association of German Laboratory Physicians and the AG Contract Coordination of the National Association of Statutory Health Insurance Physicians and the Association of Statutory Health Insurance Physicians.

Births before the 37th week of pregnancy, with a birth weight of fewer than 2,500 grams, are a key obstetric problem. Medical risk factors, such as bacterial vaginosis and infection with toxoplasmosis, can lead to an increased premature birth rate. A large proportion of premature births can be prevented by timely intervention. The early detection and reduction of these risk factors are one of the most important goals of the prevention program.

The "Hello Baby" program, which is covered for the insured of the participating sickness funds, includes:

  • Toxoplasmosis test, carried out immediately after the pregnancy is determined
  • A study and a qualified microscopic assessment of a smear on bacterial vaginal colonization, performed in the period from the 13th to the 20th week of gestation
  • An anogenital test for Streptococcus B bacteria, conducted between the 35th and the 37th week of pregnancy

As of July 1, 2019, the insured of the participating sickness funds can take advantage of the special benefits of the "Hello Baby" contract from participating gynecologists in the districts of 16 state sickness funds associations.

The full details in German can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more